Results 211 to 220 of about 2,397,304 (343)

Data from Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery

open access: gold, 2023
Servando Hernandez Vargas   +9 more
openalex   +1 more source

Attribute Preferences for Somatostatin Analogues in Neuroendocrine Tumours (NETs) Among Patients, Clinicians and Nurses in Australia

open access: yesCancer Medicine, Volume 14, Issue 21, November 2025.
ABSTRACT Background Long‐acting somatostatin analogues (LA SSAs) are commonly used as first‐line treatment in well‐differentiated low and intermediate grade 1–2 gastroenteropancreatic neuroendocrine tumours (GEP‐NETs). As a long‐term treatment option for NETs, treatment preferences should be taken into consideration.
Simon J. Fifer   +3 more
wiley   +1 more source

Pancreatic Intraductal Papillary Mucinous Neoplasm With Invasive Carcinoma Concomitant With Ampullary Neuroendocrine Tumor: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT This case reports a rare co‐occurrence of pancreatic intraductal papillary mucinous neoplasm with invasive carcinoma and ampullary neuroendocrine tumor. Laparoscopic pancreaticoduodenectomy was done. No recurrence/metastasis in 12‐month follow‐up, though both tumors had lymph node metastasis, warranting attention to timely biopsy.
Jingcheng Zhang   +4 more
wiley   +1 more source

Challenges in Diagnosis and Management of Ovarian Neuroendocrine Carcinoma: A Case of Aggressive Disease With Multimodal Treatment Approach

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Neuroendocrine tumors (NETs) of the ovary are extremely rare, accounting for only 1%–2% of malignant ovarian tumors, with high‐grade subtypes demonstrating particularly aggressive behavior. We describe a 47‐year‐old woman who presented with abdominal swelling, irregular bleeding, and pain, and was diagnosed with high‐grade ovarian ...
Javeria Haider   +6 more
wiley   +1 more source

Honey Bee Allatostatins Target Galanin/Somatostatin-Like Receptors and Modulate Learning: A Conserved Function?

open access: gold, 2016
Elodie Urlacher   +8 more
openalex   +2 more sources

Pathological Complete Response in a Rare Case of Rectal Small Cell Neuroendocrine Carcinoma Following Neoadjuvant Radiochemotherapy: A Case Report

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Rectal neuroendocrine neoplasms are rare, aggressive tumors comprising a small fraction of rectal malignancies but with increasing incidence due to improved endoscopic detection. Small cell neuroendocrine carcinoma, a high‐grade variant, poses significant diagnostic and therapeutic challenges due to its rapid progression and poor prognosis. We
Abhisek Jha   +8 more
wiley   +1 more source

Histopathological Evaluation of Somatostatin Receptor 2 Expression in Myocarditis-Rationale for the Diagnostic Use of Somatostatin Receptor Imaging. [PDF]

open access: yesDiagnostics (Basel)
Polte CL   +10 more
europepmc   +1 more source

Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study

open access: yesJournal of Nuclear Medicine, 2014
D. Wild   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy